Impact of COVID-19 on medical cannabis purchasing among Canadian patients 2020

Based on a survey conducted in July-August 2020, this statistic illustrates the impact of the COVID-19 pandemic on the ability to access medical cannabis among Canadian patients, by medical document status. Respondents who had a medical document reported a greater impact from the pandemic than those who did not have one. In Canada, a medical document from a healthcare professional is required to purchase medical marijuana from a licensed producer.

基于2020年7月至8月进行的一项调查，本统计数据显示了COVID-19疫情对加拿大患者获取医用大麻能力的影响，按医疗文件状态分类。拥有医疗文件的受访者报告称，疫情对其影响大于没有医疗文件的受访者。在加拿大，患者需持有来自医疗保健专业人员的医疗文件，方可从持牌生产商处购买医用大麻。